Safety and Effectiveness of Ureteral DJ Stent With Magnet (Blackstar, Urotech) Removal Under Ultrasound Control

April 12, 2022 updated by: nariman.gadjiev, St. Petersburg State Pavlov Medical University

A Single-center Randomized, Controlled Study Evaluating Safety and Effectiveness of Ureteral dj Stent With Magnet (Blackstar, Urotech), Stent-related Symptoms and Pain Level After Stent Removal Compared With Conventional Stent Removal With Flexible Cystoscope

Evaluation of safety and effectiveness of ureteral DJ stent with magnet (Blackstar, Urotech), severity of stent-association symptoms and pain level syndrome after stent extraction compared with stent extraction by flexible cystoscope

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Inclusion Criteria:

  • age from 18 to 70 years
  • males
  • Indications for rigid or flexible URS
  • ASA score: 1-3

Exclusion Criteria:

  • Active urinary tract infection
  • taking alpha-1 adreno and M-cholinoblockers

All patients will be randomized into 2 groups:

  • group A - male patients who will undergo ureteral stent placement by conventional polyurethane DJ stent, Fr 6.5. N=30
  • group B - male patients who will undergo ureteral stent placement by polyurethane DJ stent with magnet (Blackstar, Urotech ), Fr 7. N=30 Patients are to be assigned a randomization number that will match their treatment. Block randomization using 10 blocks is to be performed by a central randomization organization (www.randomize.net) using a computerized algorithm.

Using the Visual Analog Scale of Pain (VASP) and Ureteric Stent Symptom Questionnaire (USSQ) we are going to assess the pain syndrome and the severity of stent-associated symptoms. The USSQ will be filled twice: 3 days after stent placement and on the day of stent removal, just before the procedure. All stents will be removed 30 days after placement. Also, immediately after stent removal, patients will complete the VASP questionnaire. In the control group, the stent will be removed using flexible cystoscopy. In the experimental group under ultrasound control using a magnetic retriever, with a bladder capacity of at least 150 ml.

Primary assessed outcomes:

  1. Age
  2. Body mass index
  3. Operation side
  4. The density of the stone
  5. Type of the operation
  6. Applying of the ureteral accessing sheath
  7. Type of the ureteral stent
  8. Troubles with stent placement
  9. USSQ (Ureteral stent symptom questionnaire) 3 days after surgery
  10. USSQ before stent extraction
  11. VASP (Visual Analog Scale Pain) immediately after stent extraction
  12. Duration of stent extractiom by magnetic retrieval device
  13. Duration of stent extraction by cystoscopy
  14. Stent removal success (yes/no)

Secondary assessed outcomes:

  1. Assessment of Stone-free status after surgery by performing computed tomography of kidneys and urinary tract without intravenous contrasting 1 month after surgery
  2. Stent encrustation

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint Petersburg, Russian Federation, 197342
        • First Pavlov Saint Petersburg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • age from 18 to 70 years
  • males
  • Indications for rigid or flexible URS
  • ASA score: 1-3

Exclusion Criteria:

  • Active urinary tract infection
  • taking alpha-1 adreno and M-cholinoblockers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patients with polyurethane DJ stent
Polyurethane DJ stent, 6Fr. The stent will be removed using flexible cystoscopy.
stent extraction using magnetic retriever or flexible cystoscope
Active Comparator: Patients with polyurethane DJ stent with magnet
Polyurethane DJ stent with magnet (Blackstar, Urotech), 7Fr. The stent will be removed under ultrasound control using a magnetic retriever
stent extraction using magnetic retriever or flexible cystoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stent-related symptoms (SRS)
Time Frame: 30 days
Using USSQ to evaluate the difference of SRS in patients with different types of stent
30 days
Body pain
Time Frame: 30 days
Using VASP to evaluate the pain level in patients with different types of stent extraction
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 14, 2020

Primary Completion (Actual)

March 1, 2022

Study Completion (Actual)

March 1, 2022

Study Registration Dates

First Submitted

September 25, 2020

First Submitted That Met QC Criteria

October 3, 2020

First Posted (Actual)

October 9, 2020

Study Record Updates

Last Update Posted (Actual)

April 13, 2022

Last Update Submitted That Met QC Criteria

April 12, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 05/20-н

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urolithiasis

Clinical Trials on stent extraction

Subscribe